Kayt Sukel
From breakthrough to business: The challenging work of scaling gene-edited food for the public
When CRISPR technology first hit the scene in 2012, many saw its promise in tackling stubborn genetic diseases in humans ...
Ozempic and other GLP-1 drugs are upending the food industry. Here’s what we can expect going forward
The use of anti-obesity medications (AOMs), led by glucagon-like peptide-1 (GLP-1) agonists like Ozempic (semaglutide), has skyrocketed over the past ...